1,3-Diphenylurea

CAS No. 102-07-8

1,3-Diphenylurea( Carbanilide | Acardite | Diphenylurea, AD-30 | BRN 0782650 )

Catalog No. M17755 CAS No. 102-07-8

1, 3-Diphenylurea is involved with Epoxide hydrolase activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG 45 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1,3-Diphenylurea
  • Note
    Research use only, not for human use.
  • Brief Description
    1, 3-Diphenylurea is involved with Epoxide hydrolase activity.
  • Description
    Carbanilide, also known as diphenylurea, has many derivatives that have been used to treat a number of medical conditions. These include treatments for Alzheimer's, protozoal infections, and certain tumors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Carbanilide | Acardite | Diphenylurea, AD-30 | BRN 0782650
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Carbonic Anhydrase
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    102-07-8
  • Formula Weight
    212.25
  • Molecular Formula
    C13H12N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    c1ccccc1NC(=O)Nc1ccccc1
  • Chemical Name
    1,3-Diphenylurea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Huang W, et al. Bioorg Med Chem. 2010 Aug 1;18(15):5610-5.
molnova catalog
related products
  • Methazolamide

    Methazolamide is a carbonic anhydrase inhibitor used to treat glaucoma.

  • Levosimendan

    Levosimendan is a calcium sensitizer acting through calcium-dependent binding to cardiac troponin C (cTnC), provides treatment for heart failure.

  • Carbonic anhydrase i...

    Carbonic anhydrase inhibitor 6 is a potent human carbonic anhydrase (hCA) inhibitor that inhibits hCA IX, hCA II, hCA XII, and hCA I. It is used in the study of diseases caused by abnormalities in carbonic anhydrase.